CONSENT SOLICITATION

Company

ENDRA Life Sciences Inc.

Filed

August 3, 2020

Period of Report

August 13, 2020

Accession Number

0001654954-20-008321

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →